AOU Ospedali Riuniti di Ancona

Torrette, Ancona 60126

0 studies enrolling now · 2 studies all time

What they study most

HER2-positive Breast Cancer, Urothelial Cancer

Studies at this site

• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed